These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 7336980

  • 1. The use of HPLC to elucidate the metabolism and urinary excretion of furosemide and its metabolic products.
    Andreasen F, Christensen CK, Jakobsen FK, Mogensen CE.
    Acta Pharmacol Toxicol (Copenh); 1981 Sep; 49(3):223-9. PubMed ID: 7336980
    [Abstract] [Full Text] [Related]

  • 2. The urinary excretion of frusemide and its metabolites by kidney transplant patients.
    Nakahama H, Miwa Y, Yamaji A, Orita Y, Fukuhara Y, Yanase M, Kamada T, Sonoda T, Ishibasi M, Ichikawa Y.
    Eur J Clin Pharmacol; 1987 Sep; 32(3):313-5. PubMed ID: 3297734
    [Abstract] [Full Text] [Related]

  • 3. Biotransformation of furosemide in kidney transplant patients.
    Smith DE, Benet LZ.
    Eur J Clin Pharmacol; 1983 Sep; 24(6):787-90. PubMed ID: 6350024
    [Abstract] [Full Text] [Related]

  • 4. Biotransformation of furosemide in patients with acute pulmonary edema.
    Perez J, Sitar DS, Ogilvie RI.
    Drug Metab Dispos; 1979 Sep; 7(6):383-7. PubMed ID: 43224
    [Abstract] [Full Text] [Related]

  • 5. Absorption and disposition of furosemide in healthy volunteers, measured with a metabolite-specific assay.
    Smith DE, Lin ET, Benet LZ.
    Drug Metab Dispos; 1980 Sep; 8(5):337-42. PubMed ID: 6107232
    [Abstract] [Full Text] [Related]

  • 6. Distribution, elimination and effect of furosemide in normal subjects and in patients with heart failure.
    Andreasen F, Mikkelsen E.
    Eur J Clin Pharmacol; 1977 Aug 17; 12(1):15-22. PubMed ID: 902673
    [Abstract] [Full Text] [Related]

  • 7. Microbial models of mammalian metabolism. N-dealkylation of furosemide to yield the mammalian metabolite CSA using Cunninghamella elegans.
    Hezari M, Davis PJ.
    Drug Metab Dispos; 1992 Aug 17; 20(6):882-8. PubMed ID: 1362941
    [Abstract] [Full Text] [Related]

  • 8. Thin-layer chromatographic determination of furosemide and 4-chloro-5-sulfamoyl anthranilic acid in plasma and urine.
    Wesley-Hadzija B, Mattocks AM.
    J Chromatogr; 1982 May 14; 229(2):425-32. PubMed ID: 7096477
    [No Abstract] [Full Text] [Related]

  • 9. Determination of furosemide in urine samples by direct injection in a micellar liquid chromatographic system.
    Carda-Broch S, Esteve-Romero J, Ruiz-Angel MJ, García-Alvarez-Coque MC.
    Analyst; 2002 Jan 14; 127(1):29-34. PubMed ID: 11827392
    [Abstract] [Full Text] [Related]

  • 10. On the fate of furosemide in man.
    Beermann B, Dalén E, Lindström B, Rosén A.
    Eur J Clin Pharmacol; 1975 Oct 10; 9(1):51-61. PubMed ID: 1233253
    [Abstract] [Full Text] [Related]

  • 11. Absorption, distribution, metabolism, and excretion of furosemide in dogs and monkeys I: analytical methodology, metabolism, and urinary excretion.
    Yakatan GJ, Maness DD, Scholler J, Novick WJ, Doluisio JT.
    J Pharm Sci; 1976 Oct 10; 65(10):1456-60. PubMed ID: 824434
    [Abstract] [Full Text] [Related]

  • 12. Separation and quantitative analysis of furosemide and 4-chloro-5-sulfamoylanthranilic adid (CSA) by high pressure liquid chromatography.
    MacDougall ML, Shoeman DW, Azarnoff DL.
    Res Commun Chem Pathol Pharmacol; 1975 Feb 10; 10(2):285-92. PubMed ID: 1153837
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic, biliary excretion, and metabolic studies of 14C-furosemide in the rat.
    Prandota J, Pruitt AW.
    Xenobiotica; 1991 Jun 10; 21(6):725-36. PubMed ID: 1949904
    [Abstract] [Full Text] [Related]

  • 14. Preliminary evaluation of furosemide-probenecid interaction in humans.
    Smith DE, Gee WL, Brater DC, Lin ET, Benet LZ.
    J Pharm Sci; 1980 May 10; 69(5):571-5. PubMed ID: 7381747
    [Abstract] [Full Text] [Related]

  • 15. The binding of furosemide to serum proteins in elderly patients: displacing effect of phenprocoumon.
    Andreasen F, Husted S.
    Acta Pharmacol Toxicol (Copenh); 1980 Sep 10; 47(3):202-7. PubMed ID: 7446136
    [Abstract] [Full Text] [Related]

  • 16. [Analyses for furosemide and its metabolite in body fluids and urine of rabbit by high performance liquid chromatography].
    Yoshitomi H, Ikeda K, Goto S.
    Yakugaku Zasshi; 1982 Dec 10; 102(12):1171-6. PubMed ID: 7182451
    [No Abstract] [Full Text] [Related]

  • 17. Metabolic clearance of furosemide in the rat.
    Wallin JD, Ryals P, Kaplowitz N.
    J Pharmacol Exp Ther; 1977 Jan 10; 200(1):52-7. PubMed ID: 833762
    [Abstract] [Full Text] [Related]

  • 18. Anthranilic acid metabolism in the isolated perfused rat liver: detection and determination of anthranilic acid and its related substances using high-performance liquid chromatography with electrochemical detection.
    Naito J, Sasaki E, Ohta Y, Shinohara R, Ishiguro I.
    Biochem Pharmacol; 1984 Oct 15; 33(20):3195-200. PubMed ID: 6548385
    [Abstract] [Full Text] [Related]

  • 19. Plasma and urinary kinetics of furosemide in newborn infants.
    Tuck S, Morselli P, Broquaire M, Vert P.
    J Pediatr; 1983 Sep 15; 103(3):481-5. PubMed ID: 6886918
    [Abstract] [Full Text] [Related]

  • 20. Bumetanide and furosemide.
    Brater DC, Chennavasin P, Day B, Burdette A, Anderson S.
    Clin Pharmacol Ther; 1983 Aug 15; 34(2):207-13. PubMed ID: 6872415
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.